ITGAM and malignant colon neoplasm: In AOM/DSS-induced colon cancer mouse model, cetuximab (anti-EGFR antibody) treatment inhibited total F4/80+/CD11b+ TAMs and M2 (F4/80+/CD206+) TAM accumulation (148).